Global Biobanking Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Biobanking market size was valued at US$ 3662 million in 2025 and is forecast to a readjusted size of US$ 5751 million by 2032 with a CAGR of 6.7% during review period.
Biobanking is the end-to-end infrastructure and operating system that manages biospecimens and their associated data across the full life cycle—standardized collection, processing, quality control, aliquoting, storage, traceability, and compliant access. It covers human and non-human samples (e.g., blood, tissue, cells, DNA/RNA, and other biofluids) and integrates clinical phenotypes, longitudinal follow-up, omics outputs, and metadata under a single governance and quality framework.
Multi-omics, precision medicine, and translational R&D are pushing demand for high-quality, reusable, and traceable specimens that can withstand stringent analytical and regulatory expectations. As clinical development increasingly relies on biomarker-guided stratification and companion diagnostics, biobanks are evolving from local repositories into collaborative platforms that enable cross-site studies and consistent evidence generation. Maturing global quality and best-practice frameworks further accelerate institutional adoption by formalizing competence, process control, and governance expectations. Key constraints concentrate on compliance, consistency, and operational resilience. Divergent interpretations around secondary use, broad consent, and research exemptions can complicate multi-country collaboration and data sharing; variability in pre-analytics, freeze–thaw handling, and metadata completeness can undermine reproducibility and reduce the scientific value of collections. On the operational side, ultra-low-temperature infrastructure, liquid-nitrogen safety, redundancy planning, and incident response are essential to prevent irreversible loss of specimen integrity and institutional trust. Demand is shifting from “store samples” to “deliver evidence”: biopharma seeks collections that are directly usable for biomarker discovery, patient stratification, and diagnostic development; hospitals and academia emphasize cohort building, longitudinal follow-up, and multi-center sharing; CROs and testing labs require stronger traceability and standardized data interfaces. In parallel, dynamic consent models, auditable governance, privacy-enhancing approaches, and federated collaboration patterns are gaining momentum as pathways to scale access while maintaining compliance and participant trust. The upstream stack combines consumables, cold-chain hardware, digital systems, and services. Core consumables include cryovials/cryobags, 2D-barcode labels and printing materials, racks/boxes, aliquoting tools, and stabilization buffers. Critical equipment spans ultra-low-temperature freezers, liquid-nitrogen storage, automated aliquoting and retrieval robotics, environmental monitoring and alarm sensors, backup power, and cold-chain transport tools. On the digital side, LIMS and specimen-management platforms—plus identity/access control, audit trails, and system integration—are increasingly central as biobanking converges toward automation, traceability, and compliance-ready operations.
This report is a detailed and comprehensive analysis for global Biobanking market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biobanking market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biobanking market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biobanking market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biobanking market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biobanking
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biobanking market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Kryosphere, Precision for Medicine, Azenta, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biobanking market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biobanking product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biobanking, with revenue, gross margin, and global market share of Biobanking from 2021 to 2026.
Chapter 3, the Biobanking competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biobanking market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biobanking.
Chapter 13, to describe Biobanking research findings and conclusion.
Biobanking is the end-to-end infrastructure and operating system that manages biospecimens and their associated data across the full life cycle—standardized collection, processing, quality control, aliquoting, storage, traceability, and compliant access. It covers human and non-human samples (e.g., blood, tissue, cells, DNA/RNA, and other biofluids) and integrates clinical phenotypes, longitudinal follow-up, omics outputs, and metadata under a single governance and quality framework.
Multi-omics, precision medicine, and translational R&D are pushing demand for high-quality, reusable, and traceable specimens that can withstand stringent analytical and regulatory expectations. As clinical development increasingly relies on biomarker-guided stratification and companion diagnostics, biobanks are evolving from local repositories into collaborative platforms that enable cross-site studies and consistent evidence generation. Maturing global quality and best-practice frameworks further accelerate institutional adoption by formalizing competence, process control, and governance expectations. Key constraints concentrate on compliance, consistency, and operational resilience. Divergent interpretations around secondary use, broad consent, and research exemptions can complicate multi-country collaboration and data sharing; variability in pre-analytics, freeze–thaw handling, and metadata completeness can undermine reproducibility and reduce the scientific value of collections. On the operational side, ultra-low-temperature infrastructure, liquid-nitrogen safety, redundancy planning, and incident response are essential to prevent irreversible loss of specimen integrity and institutional trust. Demand is shifting from “store samples” to “deliver evidence”: biopharma seeks collections that are directly usable for biomarker discovery, patient stratification, and diagnostic development; hospitals and academia emphasize cohort building, longitudinal follow-up, and multi-center sharing; CROs and testing labs require stronger traceability and standardized data interfaces. In parallel, dynamic consent models, auditable governance, privacy-enhancing approaches, and federated collaboration patterns are gaining momentum as pathways to scale access while maintaining compliance and participant trust. The upstream stack combines consumables, cold-chain hardware, digital systems, and services. Core consumables include cryovials/cryobags, 2D-barcode labels and printing materials, racks/boxes, aliquoting tools, and stabilization buffers. Critical equipment spans ultra-low-temperature freezers, liquid-nitrogen storage, automated aliquoting and retrieval robotics, environmental monitoring and alarm sensors, backup power, and cold-chain transport tools. On the digital side, LIMS and specimen-management platforms—plus identity/access control, audit trails, and system integration—are increasingly central as biobanking converges toward automation, traceability, and compliance-ready operations.
This report is a detailed and comprehensive analysis for global Biobanking market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biobanking market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biobanking market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biobanking market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biobanking market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biobanking
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biobanking market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Kryosphere, Precision for Medicine, Azenta, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biobanking market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Blood
- Tissue
- Cells
- Other
- Ambient
- 2–8°C Refrigerated
- -20°C Freezer
- -80°C ULT
- Other
- Oncology
- Immunology
- Infectious Disease
- Public Health
- Metabolic
- Other
- Life Sciences and Medicine
- Hospitals
- Research Institutions
- Other
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Kryosphere
- Precision for Medicine
- Azenta
- QIAGEN
- Vigilant Bioservices
- Lifeline Scientific
- Masy BioServices
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biobanking product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biobanking, with revenue, gross margin, and global market share of Biobanking from 2021 to 2026.
Chapter 3, the Biobanking competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biobanking market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biobanking.
Chapter 13, to describe Biobanking research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biobanking by Type
1.3.1 Overview: Global Biobanking Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Biobanking Consumption Value Market Share by Type in 2025
1.3.3 Blood
1.3.4 Tissue
1.3.5 Cells
1.3.6 Other
1.4 Classification of Biobanking by Storage Temperature Tier
1.4.1 Overview: Global Biobanking Market Size by Storage Temperature Tier: 2021 Versus 2025 Versus 2032
1.4.2 Global Biobanking Consumption Value Market Share by Storage Temperature Tier in 2025
1.4.3 Ambient
1.4.4 2–8°C Refrigerated
1.4.5 -20°C Freezer
1.4.6 -80°C ULT
1.4.7 Other
1.5 Classification of Biobanking by Research Focus
1.5.1 Overview: Global Biobanking Market Size by Research Focus: 2021 Versus 2025 Versus 2032
1.5.2 Global Biobanking Consumption Value Market Share by Research Focus in 2025
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Infectious Disease
1.5.6 Public Health
1.5.7 Metabolic
1.5.8 Other
1.6 Global Biobanking Market by Application
1.6.1 Overview: Global Biobanking Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Life Sciences and Medicine
1.6.3 Hospitals
1.6.4 Research Institutions
1.6.5 Other
1.7 Global Biobanking Market Size & Forecast
1.8 Global Biobanking Market Size and Forecast by Region
1.8.1 Global Biobanking Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Biobanking Market Size by Region, (2021-2032)
1.8.3 North America Biobanking Market Size and Prospect (2021-2032)
1.8.4 Europe Biobanking Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Biobanking Market Size and Prospect (2021-2032)
1.8.6 South America Biobanking Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Biobanking Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Biobanking Product and Solutions
2.1.4 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Biobanking Product and Solutions
2.2.4 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Panasonic
2.3.1 Panasonic Details
2.3.2 Panasonic Major Business
2.3.3 Panasonic Biobanking Product and Solutions
2.3.4 Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Panasonic Recent Developments and Future Plans
2.4 SOL Group
2.4.1 SOL Group Details
2.4.2 SOL Group Major Business
2.4.3 SOL Group Biobanking Product and Solutions
2.4.4 SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SOL Group Recent Developments and Future Plans
2.5 Promega
2.5.1 Promega Details
2.5.2 Promega Major Business
2.5.3 Promega Biobanking Product and Solutions
2.5.4 Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Promega Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Biobanking Product and Solutions
2.6.4 Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Merck Recent Developments and Future Plans
2.7 Greiner Bio One
2.7.1 Greiner Bio One Details
2.7.2 Greiner Bio One Major Business
2.7.3 Greiner Bio One Biobanking Product and Solutions
2.7.4 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Greiner Bio One Recent Developments and Future Plans
2.8 Kryosphere
2.8.1 Kryosphere Details
2.8.2 Kryosphere Major Business
2.8.3 Kryosphere Biobanking Product and Solutions
2.8.4 Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Kryosphere Recent Developments and Future Plans
2.9 Precision for Medicine
2.9.1 Precision for Medicine Details
2.9.2 Precision for Medicine Major Business
2.9.3 Precision for Medicine Biobanking Product and Solutions
2.9.4 Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Precision for Medicine Recent Developments and Future Plans
2.10 Azenta
2.10.1 Azenta Details
2.10.2 Azenta Major Business
2.10.3 Azenta Biobanking Product and Solutions
2.10.4 Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Azenta Recent Developments and Future Plans
2.11 QIAGEN
2.11.1 QIAGEN Details
2.11.2 QIAGEN Major Business
2.11.3 QIAGEN Biobanking Product and Solutions
2.11.4 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 QIAGEN Recent Developments and Future Plans
2.12 Vigilant Bioservices
2.12.1 Vigilant Bioservices Details
2.12.2 Vigilant Bioservices Major Business
2.12.3 Vigilant Bioservices Biobanking Product and Solutions
2.12.4 Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Vigilant Bioservices Recent Developments and Future Plans
2.13 Lifeline Scientific
2.13.1 Lifeline Scientific Details
2.13.2 Lifeline Scientific Major Business
2.13.3 Lifeline Scientific Biobanking Product and Solutions
2.13.4 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Lifeline Scientific Recent Developments and Future Plans
2.14 Masy BioServices
2.14.1 Masy BioServices Details
2.14.2 Masy BioServices Major Business
2.14.3 Masy BioServices Biobanking Product and Solutions
2.14.4 Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Masy BioServices Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biobanking Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Biobanking by Company Revenue
3.2.2 Top 3 Biobanking Players Market Share in 2025
3.2.3 Top 6 Biobanking Players Market Share in 2025
3.3 Biobanking Market: Overall Company Footprint Analysis
3.3.1 Biobanking Market: Region Footprint
3.3.2 Biobanking Market: Company Product Type Footprint
3.3.3 Biobanking Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biobanking Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biobanking Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biobanking Consumption Value Market Share by Application (2021-2026)
5.2 Global Biobanking Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Biobanking Consumption Value by Type (2021-2032)
6.2 North America Biobanking Market Size by Application (2021-2032)
6.3 North America Biobanking Market Size by Country
6.3.1 North America Biobanking Consumption Value by Country (2021-2032)
6.3.2 United States Biobanking Market Size and Forecast (2021-2032)
6.3.3 Canada Biobanking Market Size and Forecast (2021-2032)
6.3.4 Mexico Biobanking Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Biobanking Consumption Value by Type (2021-2032)
7.2 Europe Biobanking Consumption Value by Application (2021-2032)
7.3 Europe Biobanking Market Size by Country
7.3.1 Europe Biobanking Consumption Value by Country (2021-2032)
7.3.2 Germany Biobanking Market Size and Forecast (2021-2032)
7.3.3 France Biobanking Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Biobanking Market Size and Forecast (2021-2032)
7.3.5 Russia Biobanking Market Size and Forecast (2021-2032)
7.3.6 Italy Biobanking Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biobanking Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Biobanking Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Biobanking Market Size by Region
8.3.1 Asia-Pacific Biobanking Consumption Value by Region (2021-2032)
8.3.2 China Biobanking Market Size and Forecast (2021-2032)
8.3.3 Japan Biobanking Market Size and Forecast (2021-2032)
8.3.4 South Korea Biobanking Market Size and Forecast (2021-2032)
8.3.5 India Biobanking Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Biobanking Market Size and Forecast (2021-2032)
8.3.7 Australia Biobanking Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Biobanking Consumption Value by Type (2021-2032)
9.2 South America Biobanking Consumption Value by Application (2021-2032)
9.3 South America Biobanking Market Size by Country
9.3.1 South America Biobanking Consumption Value by Country (2021-2032)
9.3.2 Brazil Biobanking Market Size and Forecast (2021-2032)
9.3.3 Argentina Biobanking Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biobanking Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Biobanking Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Biobanking Market Size by Country
10.3.1 Middle East & Africa Biobanking Consumption Value by Country (2021-2032)
10.3.2 Turkey Biobanking Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Biobanking Market Size and Forecast (2021-2032)
10.3.4 UAE Biobanking Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Biobanking Market Drivers
11.2 Biobanking Market Restraints
11.3 Biobanking Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biobanking Industry Chain
12.2 Biobanking Upstream Analysis
12.3 Biobanking Midstream Analysis
12.4 Biobanking Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biobanking by Type
1.3.1 Overview: Global Biobanking Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Biobanking Consumption Value Market Share by Type in 2025
1.3.3 Blood
1.3.4 Tissue
1.3.5 Cells
1.3.6 Other
1.4 Classification of Biobanking by Storage Temperature Tier
1.4.1 Overview: Global Biobanking Market Size by Storage Temperature Tier: 2021 Versus 2025 Versus 2032
1.4.2 Global Biobanking Consumption Value Market Share by Storage Temperature Tier in 2025
1.4.3 Ambient
1.4.4 2–8°C Refrigerated
1.4.5 -20°C Freezer
1.4.6 -80°C ULT
1.4.7 Other
1.5 Classification of Biobanking by Research Focus
1.5.1 Overview: Global Biobanking Market Size by Research Focus: 2021 Versus 2025 Versus 2032
1.5.2 Global Biobanking Consumption Value Market Share by Research Focus in 2025
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Infectious Disease
1.5.6 Public Health
1.5.7 Metabolic
1.5.8 Other
1.6 Global Biobanking Market by Application
1.6.1 Overview: Global Biobanking Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Life Sciences and Medicine
1.6.3 Hospitals
1.6.4 Research Institutions
1.6.5 Other
1.7 Global Biobanking Market Size & Forecast
1.8 Global Biobanking Market Size and Forecast by Region
1.8.1 Global Biobanking Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Biobanking Market Size by Region, (2021-2032)
1.8.3 North America Biobanking Market Size and Prospect (2021-2032)
1.8.4 Europe Biobanking Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Biobanking Market Size and Prospect (2021-2032)
1.8.6 South America Biobanking Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Biobanking Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Biobanking Product and Solutions
2.1.4 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Biobanking Product and Solutions
2.2.4 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Panasonic
2.3.1 Panasonic Details
2.3.2 Panasonic Major Business
2.3.3 Panasonic Biobanking Product and Solutions
2.3.4 Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Panasonic Recent Developments and Future Plans
2.4 SOL Group
2.4.1 SOL Group Details
2.4.2 SOL Group Major Business
2.4.3 SOL Group Biobanking Product and Solutions
2.4.4 SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 SOL Group Recent Developments and Future Plans
2.5 Promega
2.5.1 Promega Details
2.5.2 Promega Major Business
2.5.3 Promega Biobanking Product and Solutions
2.5.4 Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Promega Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Biobanking Product and Solutions
2.6.4 Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Merck Recent Developments and Future Plans
2.7 Greiner Bio One
2.7.1 Greiner Bio One Details
2.7.2 Greiner Bio One Major Business
2.7.3 Greiner Bio One Biobanking Product and Solutions
2.7.4 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Greiner Bio One Recent Developments and Future Plans
2.8 Kryosphere
2.8.1 Kryosphere Details
2.8.2 Kryosphere Major Business
2.8.3 Kryosphere Biobanking Product and Solutions
2.8.4 Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Kryosphere Recent Developments and Future Plans
2.9 Precision for Medicine
2.9.1 Precision for Medicine Details
2.9.2 Precision for Medicine Major Business
2.9.3 Precision for Medicine Biobanking Product and Solutions
2.9.4 Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Precision for Medicine Recent Developments and Future Plans
2.10 Azenta
2.10.1 Azenta Details
2.10.2 Azenta Major Business
2.10.3 Azenta Biobanking Product and Solutions
2.10.4 Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Azenta Recent Developments and Future Plans
2.11 QIAGEN
2.11.1 QIAGEN Details
2.11.2 QIAGEN Major Business
2.11.3 QIAGEN Biobanking Product and Solutions
2.11.4 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 QIAGEN Recent Developments and Future Plans
2.12 Vigilant Bioservices
2.12.1 Vigilant Bioservices Details
2.12.2 Vigilant Bioservices Major Business
2.12.3 Vigilant Bioservices Biobanking Product and Solutions
2.12.4 Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Vigilant Bioservices Recent Developments and Future Plans
2.13 Lifeline Scientific
2.13.1 Lifeline Scientific Details
2.13.2 Lifeline Scientific Major Business
2.13.3 Lifeline Scientific Biobanking Product and Solutions
2.13.4 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Lifeline Scientific Recent Developments and Future Plans
2.14 Masy BioServices
2.14.1 Masy BioServices Details
2.14.2 Masy BioServices Major Business
2.14.3 Masy BioServices Biobanking Product and Solutions
2.14.4 Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Masy BioServices Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biobanking Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Biobanking by Company Revenue
3.2.2 Top 3 Biobanking Players Market Share in 2025
3.2.3 Top 6 Biobanking Players Market Share in 2025
3.3 Biobanking Market: Overall Company Footprint Analysis
3.3.1 Biobanking Market: Region Footprint
3.3.2 Biobanking Market: Company Product Type Footprint
3.3.3 Biobanking Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biobanking Consumption Value and Market Share by Type (2021-2026)
4.2 Global Biobanking Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biobanking Consumption Value Market Share by Application (2021-2026)
5.2 Global Biobanking Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Biobanking Consumption Value by Type (2021-2032)
6.2 North America Biobanking Market Size by Application (2021-2032)
6.3 North America Biobanking Market Size by Country
6.3.1 North America Biobanking Consumption Value by Country (2021-2032)
6.3.2 United States Biobanking Market Size and Forecast (2021-2032)
6.3.3 Canada Biobanking Market Size and Forecast (2021-2032)
6.3.4 Mexico Biobanking Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Biobanking Consumption Value by Type (2021-2032)
7.2 Europe Biobanking Consumption Value by Application (2021-2032)
7.3 Europe Biobanking Market Size by Country
7.3.1 Europe Biobanking Consumption Value by Country (2021-2032)
7.3.2 Germany Biobanking Market Size and Forecast (2021-2032)
7.3.3 France Biobanking Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Biobanking Market Size and Forecast (2021-2032)
7.3.5 Russia Biobanking Market Size and Forecast (2021-2032)
7.3.6 Italy Biobanking Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biobanking Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Biobanking Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Biobanking Market Size by Region
8.3.1 Asia-Pacific Biobanking Consumption Value by Region (2021-2032)
8.3.2 China Biobanking Market Size and Forecast (2021-2032)
8.3.3 Japan Biobanking Market Size and Forecast (2021-2032)
8.3.4 South Korea Biobanking Market Size and Forecast (2021-2032)
8.3.5 India Biobanking Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Biobanking Market Size and Forecast (2021-2032)
8.3.7 Australia Biobanking Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Biobanking Consumption Value by Type (2021-2032)
9.2 South America Biobanking Consumption Value by Application (2021-2032)
9.3 South America Biobanking Market Size by Country
9.3.1 South America Biobanking Consumption Value by Country (2021-2032)
9.3.2 Brazil Biobanking Market Size and Forecast (2021-2032)
9.3.3 Argentina Biobanking Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biobanking Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Biobanking Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Biobanking Market Size by Country
10.3.1 Middle East & Africa Biobanking Consumption Value by Country (2021-2032)
10.3.2 Turkey Biobanking Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Biobanking Market Size and Forecast (2021-2032)
10.3.4 UAE Biobanking Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Biobanking Market Drivers
11.2 Biobanking Market Restraints
11.3 Biobanking Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biobanking Industry Chain
12.2 Biobanking Upstream Analysis
12.3 Biobanking Midstream Analysis
12.4 Biobanking Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biobanking Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biobanking Consumption Value by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biobanking Consumption Value by Research Focus, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biobanking Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Biobanking Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Major Business
Table 9. Thermo Fisher Biobanking Product and Solutions
Table 10. Thermo Fisher Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Recent Developments and Future Plans
Table 12. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 13. Beckman Coulter Major Business
Table 14. Beckman Coulter Biobanking Product and Solutions
Table 15. Beckman Coulter Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Beckman Coulter Recent Developments and Future Plans
Table 17. Panasonic Company Information, Head Office, and Major Competitors
Table 18. Panasonic Major Business
Table 19. Panasonic Biobanking Product and Solutions
Table 20. Panasonic Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. SOL Group Company Information, Head Office, and Major Competitors
Table 22. SOL Group Major Business
Table 23. SOL Group Biobanking Product and Solutions
Table 24. SOL Group Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. SOL Group Recent Developments and Future Plans
Table 26. Promega Company Information, Head Office, and Major Competitors
Table 27. Promega Major Business
Table 28. Promega Biobanking Product and Solutions
Table 29. Promega Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Promega Recent Developments and Future Plans
Table 31. Merck Company Information, Head Office, and Major Competitors
Table 32. Merck Major Business
Table 33. Merck Biobanking Product and Solutions
Table 34. Merck Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Merck Recent Developments and Future Plans
Table 36. Greiner Bio One Company Information, Head Office, and Major Competitors
Table 37. Greiner Bio One Major Business
Table 38. Greiner Bio One Biobanking Product and Solutions
Table 39. Greiner Bio One Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Greiner Bio One Recent Developments and Future Plans
Table 41. Kryosphere Company Information, Head Office, and Major Competitors
Table 42. Kryosphere Major Business
Table 43. Kryosphere Biobanking Product and Solutions
Table 44. Kryosphere Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Kryosphere Recent Developments and Future Plans
Table 46. Precision for Medicine Company Information, Head Office, and Major Competitors
Table 47. Precision for Medicine Major Business
Table 48. Precision for Medicine Biobanking Product and Solutions
Table 49. Precision for Medicine Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Precision for Medicine Recent Developments and Future Plans
Table 51. Azenta Company Information, Head Office, and Major Competitors
Table 52. Azenta Major Business
Table 53. Azenta Biobanking Product and Solutions
Table 54. Azenta Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Azenta Recent Developments and Future Plans
Table 56. QIAGEN Company Information, Head Office, and Major Competitors
Table 57. QIAGEN Major Business
Table 58. QIAGEN Biobanking Product and Solutions
Table 59. QIAGEN Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. QIAGEN Recent Developments and Future Plans
Table 61. Vigilant Bioservices Company Information, Head Office, and Major Competitors
Table 62. Vigilant Bioservices Major Business
Table 63. Vigilant Bioservices Biobanking Product and Solutions
Table 64. Vigilant Bioservices Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Vigilant Bioservices Recent Developments and Future Plans
Table 66. Lifeline Scientific Company Information, Head Office, and Major Competitors
Table 67. Lifeline Scientific Major Business
Table 68. Lifeline Scientific Biobanking Product and Solutions
Table 69. Lifeline Scientific Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Lifeline Scientific Recent Developments and Future Plans
Table 71. Masy BioServices Company Information, Head Office, and Major Competitors
Table 72. Masy BioServices Major Business
Table 73. Masy BioServices Biobanking Product and Solutions
Table 74. Masy BioServices Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Masy BioServices Recent Developments and Future Plans
Table 76. Global Biobanking Revenue (USD Million) by Players (2021-2026)
Table 77. Global Biobanking Revenue Share by Players (2021-2026)
Table 78. Breakdown of Biobanking by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in Biobanking, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key Biobanking Players
Table 81. Biobanking Market: Company Product Type Footprint
Table 82. Biobanking Market: Company Product Application Footprint
Table 83. Biobanking New Market Entrants and Barriers to Market Entry
Table 84. Biobanking Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global Biobanking Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global Biobanking Consumption Value Share by Type (2021-2026)
Table 87. Global Biobanking Consumption Value Forecast by Type (2027-2032)
Table 88. Global Biobanking Consumption Value by Application (2021-2026)
Table 89. Global Biobanking Consumption Value Forecast by Application (2027-2032)
Table 90. North America Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific Biobanking Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of Biobanking Upstream (Raw Materials)
Table 121. Global Biobanking Typical Customers
Table 1. Global Biobanking Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biobanking Consumption Value by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biobanking Consumption Value by Research Focus, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biobanking Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Biobanking Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Major Business
Table 9. Thermo Fisher Biobanking Product and Solutions
Table 10. Thermo Fisher Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Recent Developments and Future Plans
Table 12. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 13. Beckman Coulter Major Business
Table 14. Beckman Coulter Biobanking Product and Solutions
Table 15. Beckman Coulter Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Beckman Coulter Recent Developments and Future Plans
Table 17. Panasonic Company Information, Head Office, and Major Competitors
Table 18. Panasonic Major Business
Table 19. Panasonic Biobanking Product and Solutions
Table 20. Panasonic Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. SOL Group Company Information, Head Office, and Major Competitors
Table 22. SOL Group Major Business
Table 23. SOL Group Biobanking Product and Solutions
Table 24. SOL Group Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. SOL Group Recent Developments and Future Plans
Table 26. Promega Company Information, Head Office, and Major Competitors
Table 27. Promega Major Business
Table 28. Promega Biobanking Product and Solutions
Table 29. Promega Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Promega Recent Developments and Future Plans
Table 31. Merck Company Information, Head Office, and Major Competitors
Table 32. Merck Major Business
Table 33. Merck Biobanking Product and Solutions
Table 34. Merck Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Merck Recent Developments and Future Plans
Table 36. Greiner Bio One Company Information, Head Office, and Major Competitors
Table 37. Greiner Bio One Major Business
Table 38. Greiner Bio One Biobanking Product and Solutions
Table 39. Greiner Bio One Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Greiner Bio One Recent Developments and Future Plans
Table 41. Kryosphere Company Information, Head Office, and Major Competitors
Table 42. Kryosphere Major Business
Table 43. Kryosphere Biobanking Product and Solutions
Table 44. Kryosphere Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Kryosphere Recent Developments and Future Plans
Table 46. Precision for Medicine Company Information, Head Office, and Major Competitors
Table 47. Precision for Medicine Major Business
Table 48. Precision for Medicine Biobanking Product and Solutions
Table 49. Precision for Medicine Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Precision for Medicine Recent Developments and Future Plans
Table 51. Azenta Company Information, Head Office, and Major Competitors
Table 52. Azenta Major Business
Table 53. Azenta Biobanking Product and Solutions
Table 54. Azenta Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Azenta Recent Developments and Future Plans
Table 56. QIAGEN Company Information, Head Office, and Major Competitors
Table 57. QIAGEN Major Business
Table 58. QIAGEN Biobanking Product and Solutions
Table 59. QIAGEN Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. QIAGEN Recent Developments and Future Plans
Table 61. Vigilant Bioservices Company Information, Head Office, and Major Competitors
Table 62. Vigilant Bioservices Major Business
Table 63. Vigilant Bioservices Biobanking Product and Solutions
Table 64. Vigilant Bioservices Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Vigilant Bioservices Recent Developments and Future Plans
Table 66. Lifeline Scientific Company Information, Head Office, and Major Competitors
Table 67. Lifeline Scientific Major Business
Table 68. Lifeline Scientific Biobanking Product and Solutions
Table 69. Lifeline Scientific Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Lifeline Scientific Recent Developments and Future Plans
Table 71. Masy BioServices Company Information, Head Office, and Major Competitors
Table 72. Masy BioServices Major Business
Table 73. Masy BioServices Biobanking Product and Solutions
Table 74. Masy BioServices Biobanking Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Masy BioServices Recent Developments and Future Plans
Table 76. Global Biobanking Revenue (USD Million) by Players (2021-2026)
Table 77. Global Biobanking Revenue Share by Players (2021-2026)
Table 78. Breakdown of Biobanking by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in Biobanking, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key Biobanking Players
Table 81. Biobanking Market: Company Product Type Footprint
Table 82. Biobanking Market: Company Product Application Footprint
Table 83. Biobanking New Market Entrants and Barriers to Market Entry
Table 84. Biobanking Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global Biobanking Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global Biobanking Consumption Value Share by Type (2021-2026)
Table 87. Global Biobanking Consumption Value Forecast by Type (2027-2032)
Table 88. Global Biobanking Consumption Value by Application (2021-2026)
Table 89. Global Biobanking Consumption Value Forecast by Application (2027-2032)
Table 90. North America Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific Biobanking Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa Biobanking Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Biobanking Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa Biobanking Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Biobanking Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa Biobanking Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa Biobanking Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of Biobanking Upstream (Raw Materials)
Table 121. Global Biobanking Typical Customers
LIST OF FIGURES
Figure 1. Biobanking Picture
Figure 2. Global Biobanking Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biobanking Consumption Value Market Share by Type in 2025
Figure 4. Blood
Figure 5. Tissue
Figure 6. Cells
Figure 7. Other
Figure 8. Global Biobanking Consumption Value by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Biobanking Consumption Value Market Share by Storage Temperature Tier in 2025
Figure 10. Ambient
Figure 11. 2–8°C Refrigerated
Figure 12. -20°C Freezer
Figure 13. -80°C ULT
Figure 14. Other
Figure 15. Global Biobanking Consumption Value by Research Focus, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Biobanking Consumption Value Market Share by Research Focus in 2025
Figure 17. Oncology
Figure 18. Immunology
Figure 19. Infectious Disease
Figure 20. Public Health
Figure 21. Metabolic
Figure 22. Other
Figure 23. Global Biobanking Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 24. Biobanking Consumption Value Market Share by Application in 2025
Figure 25. Life Sciences and Medicine Picture
Figure 26. Hospitals Picture
Figure 27. Research Institutions Picture
Figure 28. Other Picture
Figure 29. Global Biobanking Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Biobanking Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Market Biobanking Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 32. Global Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 33. Global Biobanking Consumption Value Market Share by Region in 2025
Figure 34. North America Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 35. Europe Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 36. Asia-Pacific Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 37. South America Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 38. Middle East & Africa Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 39. Company Three Recent Developments and Future Plans
Figure 40. Global Biobanking Revenue Share by Players in 2025
Figure 41. Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 42. Market Share of Biobanking by Player Revenue in 2025
Figure 43. Top 3 Biobanking Players Market Share in 2025
Figure 44. Top 6 Biobanking Players Market Share in 2025
Figure 45. Global Biobanking Consumption Value Share by Type (2021-2026)
Figure 46. Global Biobanking Market Share Forecast by Type (2027-2032)
Figure 47. Global Biobanking Consumption Value Share by Application (2021-2026)
Figure 48. Global Biobanking Market Share Forecast by Application (2027-2032)
Figure 49. North America Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 50. North America Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 51. North America Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 56. Europe Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 57. Europe Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 59. France Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 66. China Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 69. India Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 73. South America Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 74. South America Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 75. Brazil Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 76. Argentina Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 77. Middle East & Africa Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 78. Middle East & Africa Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 79. Middle East & Africa Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 82. UAE Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 83. Biobanking Market Drivers
Figure 84. Biobanking Market Restraints
Figure 85. Biobanking Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Biobanking Industrial Chain
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Biobanking Picture
Figure 2. Global Biobanking Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biobanking Consumption Value Market Share by Type in 2025
Figure 4. Blood
Figure 5. Tissue
Figure 6. Cells
Figure 7. Other
Figure 8. Global Biobanking Consumption Value by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Biobanking Consumption Value Market Share by Storage Temperature Tier in 2025
Figure 10. Ambient
Figure 11. 2–8°C Refrigerated
Figure 12. -20°C Freezer
Figure 13. -80°C ULT
Figure 14. Other
Figure 15. Global Biobanking Consumption Value by Research Focus, (USD Million), 2021 & 2025 & 2032
Figure 16. Global Biobanking Consumption Value Market Share by Research Focus in 2025
Figure 17. Oncology
Figure 18. Immunology
Figure 19. Infectious Disease
Figure 20. Public Health
Figure 21. Metabolic
Figure 22. Other
Figure 23. Global Biobanking Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 24. Biobanking Consumption Value Market Share by Application in 2025
Figure 25. Life Sciences and Medicine Picture
Figure 26. Hospitals Picture
Figure 27. Research Institutions Picture
Figure 28. Other Picture
Figure 29. Global Biobanking Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 30. Global Biobanking Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 31. Global Market Biobanking Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 32. Global Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 33. Global Biobanking Consumption Value Market Share by Region in 2025
Figure 34. North America Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 35. Europe Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 36. Asia-Pacific Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 37. South America Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 38. Middle East & Africa Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 39. Company Three Recent Developments and Future Plans
Figure 40. Global Biobanking Revenue Share by Players in 2025
Figure 41. Biobanking Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 42. Market Share of Biobanking by Player Revenue in 2025
Figure 43. Top 3 Biobanking Players Market Share in 2025
Figure 44. Top 6 Biobanking Players Market Share in 2025
Figure 45. Global Biobanking Consumption Value Share by Type (2021-2026)
Figure 46. Global Biobanking Market Share Forecast by Type (2027-2032)
Figure 47. Global Biobanking Consumption Value Share by Application (2021-2026)
Figure 48. Global Biobanking Market Share Forecast by Application (2027-2032)
Figure 49. North America Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 50. North America Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 51. North America Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 52. United States Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 53. Canada Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 54. Mexico Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 55. Europe Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 56. Europe Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 57. Europe Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 58. Germany Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 59. France Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 60. United Kingdom Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 61. Russia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 62. Italy Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 63. Asia-Pacific Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 64. Asia-Pacific Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 65. Asia-Pacific Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 66. China Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 67. Japan Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 68. South Korea Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 69. India Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 70. Southeast Asia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 71. Australia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 72. South America Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 73. South America Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 74. South America Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 75. Brazil Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 76. Argentina Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 77. Middle East & Africa Biobanking Consumption Value Market Share by Type (2021-2032)
Figure 78. Middle East & Africa Biobanking Consumption Value Market Share by Application (2021-2032)
Figure 79. Middle East & Africa Biobanking Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 82. UAE Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 83. Biobanking Market Drivers
Figure 84. Biobanking Market Restraints
Figure 85. Biobanking Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Biobanking Industrial Chain
Figure 88. Methodology
Figure 89. Research Process and Data Source
